Serum levels of interleukin-6 and interleukin-10 in relation to depression scores in patients with cardiovascular risk factors

Behavioral Medicine

Volumn 37, Issue 3, 2011, Pages 105-112

  Meyer, Thomas ^a   Stanske, Beate ^b   Kochen, Michael M ^a   Cordes, Andreas ^a   Yüksel, Iraz ^a   Wachter, Rolf ^a   Lüers, Claus ^c   Scherer, Martin ^d   Binder, Lutz ^a   Pieske, Burkert ^e   Herrmann Lingen, Christoph ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF HAMBURG   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

cardiovascular patients; cytokine; Depression; interleukin; vital exhaustion

Indexed keywords

INTERLEUKIN 20; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DEPRESSION; EXHAUSTION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAASTRICHT QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; QUESTIONNAIRE; VITAL EXHAUSTION;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 80052596242     PISSN: 08964289     EISSN: 19404026     Source Type: Journal    
DOI: 10.1080/08964289.2011.609192     Document Type: Article

References (60)

1. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Rev Neuroscience. 2008;9:46-56.
2. Maes M, Ruckoanich P, Chang YS, Mahanonda N, Berk M. Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:769-783.
3. Lindmark E, Diderholm E, Wallentin L, Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: Effects of an early invasive or noninvasive strategy. JAMA. 2001;286:2107-2113.
4. Miller GE, Stetler CA, Carney RM, Freedland KE, Banks WA. Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol. 2002;90:1279-1283.
5. Empana JP, Sykes DH, Luc G, et al. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men. The Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005;111:2299-2305.
6. Pizzi C, Manzoli L, Mancini S, Costa GM. Analysis of potential predictors of depression among coronary heart disease risk factors including heart rate variability,markers of inflammation, and endothelial function. Eur Heart J. 2008;29:1110-1117.
7. Pizzi C, Manzoli L, Mancini S, Bedetti G, Fontana F, Costa GM. Autonomic nervous system, inflammation and preclinical carotid atherosclerosis in depressed subjects with coronary risk factors. Atherosclerosis. 2010;212:292-298.
8. Maes M. Evidence for an immune response in major depression: A review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11-38.
9. Rugulies R. Depression as a predictor for coronary heart disease. A review and meta-analysis. Am J Prev Med. 2002;23:51-61.
10. Jones DJ, Bromberger JT, Sutton-Tyrrell K, Matthews KA. Lifetime history of depression and carotid atherosclerosis in middle-aged women. Arch Gen Psychiatry. 2003;60:153-160.
11. Tiemeier H, vanDijck W, HofmanA,Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: The Rotterdam Study. Arch Gen Psychiatry. 2004;61:369-376.
12. Agatisa PK, Matthews KA, Bromberger JT, Edmundowicz D, Chang YF, Sutton-Tyrrell K. Coronary and aortic calcification in women with a history of major depression. Arch InternMed. 2005;165:1229-1236.
13. Elovainio M, Keltikangas-Järvinen L, Kivimäki M, et al. Depressive symptoms and carotid artery intima-media thickness in young adults: The Cardiovascular Risk in Young Finns Study. Psychosom Med. 2005;67:561-567.
14. Haas DC, Davidson KW, Schwartz DJ, et al. Depressive symptoms are independently predictive of carotid atherosclerosis. Am J Cardiol. 2005;95:547-550.
15. Faramawi MF, Gustat J,Wildman RP, et al. Relation between depressive symptoms and common carotid artery atherosclerosis in American persons =65 years of age. Am J Cardiol. 2007;99:1610-1613.
16. Stewart JC, JanickiDL, Muldoon MF, Sutton-Tyrrell K, Kamarck TW. Negative emotions and 3-year progression of subclinical atherosclerosis. Arch Gen Psychiatry. 2007;64:225-233.
17. O'Malley PG, JonesDL, Feuerstein IM, TaylorAJ. Lack of correlation between psychological factors and subclinical coronary artery disease. N Engl J Med. 2000;343:1298-1304.
18. Diez Roux AV, Ranjit N, Powell L, et al. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. Ann Intern Med. 2006;144:822-831.
19. Frasure-Smith N, Lesṕerance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
20. Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res. 2002;53:897-902.
21. Miller GE, Freedland KE, Duntley S, Carney RM. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol. 2005;95:317-321.
22. Appels A, Mulder P. Excess fatigue as a precursor of myocardial infarction. Eur Heart J. 1988;9:758-764.
23. Kop WJ, Appels AP, Mendes de Leon CF, de Swart HB, Bär FW. Vital exhaustion predicts new cardiac events after successful coronary angioplasty. Psychosom Med. 1994;56:281-287.
24. Mendes de Leon CF, Kop WJ, de Swart HB, Bär FW, Appels AP. Psychosocial characteristics and recurrent events after percutaneous transluminal coronary angioplasty. Am J Cardiol. 1996;77:252-255.
25. Bages N, Appels A, Falger PR. Vital exhaustion as a risk factor of myocardial infarction: A case-control study in Venezuela. Int J Behav Med. 1999;6:279-290.
26. Cole SR, Kawachi I, Sesso HD, Paffenbarger RS, Lee IM. Sense of exhaustion and coronary heart disease among college alumni. Am J Cardiol. 1999;84:1401-1405.
27. Koertge J,Wamala SP, Janszky I, et al.Vital exhaustion and recurrence of CHD in women with acute myocardial infarction. Psychol Health Med. 2002;7:117-126.
28. Prescott E, Holst C, Groønbæk M, Schnohr P, Jensen G, Barefoot J. Vital exhaustion as a risk factor for ischaemic heart disease and allcause mortality in a community sample. A prospective study of 4084 men and 5479 women in the Copenhagen City Heart Study. Int J Epidemiol. 2003;32:990-997.
29. Schwartz SW, Carlucci C, Chambless LE, Rosamond WD. Synergism between smoking and vital exhaustion in the risk of ischemic stroke: Evidence from the ARIC study. Ann Epidemiol. 2004;14:416-424.
30. Schuitemaker GE, Dinant GJ, van der Pol GA, Appels A. Assessment of vital exhaustion and identification of subjects at increased risk of myocardial infarction in general practice. Psychosomatics. 2004;45:414-418.
31. Schuitemaker GE, Dinant GJ, van der Pol GA, Verhelst AF, Appels A. Vital exhaustion as a risk indicator for first stroke. Psychosomatics. 2004;45:114-118.
32. Appels A, Bär FW, Bär J, Bruggeman C, de Baets M. Inflammation, depressive symptomatology, and coronary artery disease. Psychosom Med. 2000;62:601-605.
33. Kwaijtaal M, vanDiest R, Bär FW, et al. Inflammatory markers predict late cardiac events in patients who are exhausted after percutaneous coronary intervention. Atherosclerosis. 2005;182:341-348.
34. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767-1772.
35. Janszky I, Lekander M, Blom M, Georgiades A, Ahnve S. Self-rated health and vital exhaustion, but not depression, is related to inflammation in women with coronary heart disease. Brain Behav Immun. 2005;19:555-563.
36. Dhabhar FS, Burke HM, Epel ES, et al. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatric Res. 2009;43:962-969.
37. Roque S, Correia-Neves M, Mesquita AR, Palha JA, Sousa N. Interleukin-10: A key cytokine in depression? Cardiovasc Psychiatry Neurol. 2009;2009:187894.
38. Parissis JT, Farmakis D, Nikolaou M, et al. Plasma B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: A 1-year follow-up study. Eur J Heart Fail. 2009;11:967-972.
39. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67:446-457.
40. Meyer T, Stanske B, Kochen MM, et al. Elevated serum levels of interleukin-10 and tumor necrosis factor a are both associated with vital exhaustion in patients with cardiovascular risk factors. Psychosomatics. 2010;51:248-256.
41. Shelton RC, Claiborne J, Sidoryk-Wegrzynowicz M, et al. Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatry. 2011;16:751-762.
42. McGowan L, Dickens C, Percival C, Douglas J, Tomenson B, Creed F. The relationship between vital exhaustion, depression and comorbid illnesses in patients following first myocardial infarction. J Psychosom Res. 2004;57:183-188.
43. Wetzel D, Scheidt-Nave C, Rogausch A, et al. Medizinische Versorgung in der Praxis. Eine Modellstudie zur Verbesserung der hausärztlichen Versorgungsforschung in Deutschland. Z Allgemeinmed. 2003;79:394-398.
44. Himmel W, Hummers-Pradier E, Kochen MM, MedViPGruppe. Medizinische Versorgung in der hausärztlichen Praxis. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006;49:151-159.
45. Wachter R, Lüers C, Kleta S, et al. Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension. Eur J Heart Failure. 2007;9:469-476.
46. Lüers C, Wachter R, Kleta S, et al. Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction. Clin Res Cardiol. 2010;99:217-226.
47. Appels A, Höppener P, Mulder P. A questionnaire to assess premonitory symptoms of myocardial infarction. Int JCardiol. 1987;17:15-24.
48. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361-370.
49. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale. A review of validation data and clinical results. J Psychosom Res. 1997;42:17-41.
50. Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, van Hemert AM. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med. 1997;27:363-370.
51. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52:69-77.
52. Pachler C, Ikeoka D, Plank J, et al. Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab. 2007;293:E690-696.
53. Kühn R, Löhler J, Rennick D, Rajewsky K,Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 1993;75:263-274.
54. Mege JL, Meghari S, Honstettre A, Capo C, Raoult D. The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis. 2006;6:557-569.
55. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol. 2007;15:143-146.
56. O'Garra A, Vieira P. TH1 cells control themselves by producing interleukin-10. Nat Rev Immunol. 2007;7:425-428.
57. KoukkunenH, PenttiläK,Kemppainen A, et al. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. AnnMed. 2001;33:37-47.
58. Tedgui A, Mallat Z. Cytokines in atherosclerosis: Pathogenic and regulatory pathways. Physiol Rev. 2006;86:515-581.
59. Uyemura K, Demer LL, Castle SC, et al. Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest. 1996;97:2130-2138.
60. Mallat Z, Heymes C, Ohan J, Faggin E, Lesèche G, Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques. Relation to inducible nitric oxide synthase expression and cell death. Arterioscler Thromb Vasc Biol. 1999;19:611-616.